GlassScriptPhysician profile
Robert Hart Moore
NPI 1124683685
$6,280.74
in general payments reported to CMS, 2019-2025
23 companies · $3,246 in 2025
The $3,246 reported for 2025 was more than what 87% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $335 · 2023: $1,356 · 2024: $1,344 · 2025: $3,246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,876 · Travel and Lodging: $1,070.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,875.55 |
| Travel and Lodging | $1,070.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $1,856.32 | 2025 | Nanoknife |
| Coloplast Corp | $1,735.67 | 2023-2025 | Titan |
| Karl Storz Endoscopy-America | $392.26 | 2023-2024 | Flex-X, Hopkins |
| Boston Scientific Corporation | $381.82 | 2022-2025 | Ams 700, Rezum Generator |
| Sumitomo Pharma America, INC. | $263.21 | 2024-2025 | Gemtesa, Orgovyx |
| Endo USA, INC. | $199.22 | 2025 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $194.94 | 2023-2025 | Jelmyto |
| Novartis Pharmaceuticals Corporation | $189.01 | 2024-2025 | |
| Medtronic, INC. | $162.99 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $149.97 | 2025 | |
| Progenics Pharmaceuticals, INC. | $131.21 | 2024-2025 | |
| Abbvie INC. | $126.88 | 2024-2025 | |
| Janssen Biotech, INC. | $90.26 | 2025 | Erleada |
| Ferring Pharmaceuticals INC. | $77.94 | 2025 | Adstiladrin |
| Merck Sharp & Dohme LLC | $66.58 | 2024-2025 | Keytruda, Welireg |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $58.86 | 2025 | Xtandi |
| Blue Earth Diagnostics | $50.11 | 2025 | Posluma |
| Photocure INC | $49.54 | 2022 | |
| Tolmar, INC. | $30.00 | 2024 | |
| Azurity Pharmaceuticals, INC. | $21.36 | 2025 | Azmiro |
| Accord Healthcare, INC. | $20.62 | 2025 | |
| Procept Biorobotics Corporation | $19.92 | 2024 | Aquabeam System |
| Civco Medical Instruments | $12.05 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.